Richard J. Katz, MD, FACC


Richard J. Katz, MD, FACC

Richard J. Katz, MD is the director of the division of Cardiology at The George Washington University Hospital, a position he has held since 1997. He also is the Bloedorn Professor of Cardiology.

Dr. Katz is involved in numerous research studies evaluating heart failure, coronary artery disease and cardiac rhythm disorders. He has served as the principal investigator for a number of national clinical trials, including: CAST, Cardiac Arrhythmia Suppression Trial; PEACE, Prospective Evaluation of ACE Inhibitors; and BEST, Beta-blocker Evaluation of Survival Trial.

He has presented his research experiences across the country at conferences, including those hosted by the American Heart Association and the American College of Cardiology. In addition, his research findings have been published in more than 80 articles and 100 abstracts.

In 1991 he received an honorary appointment as visiting professor to both the Royal Brompton National Heart and Lung Hospital and the Hammersmith Hospital in London, England.

Dr. Katz is a Fellow of the American College of Cardiology and served as their governor of the District of Columbia from 1997-2000. He also serves on the editorial boards of Cardiology Review and the British Journal of Cardiology. Dr. Katz is a reviewer for Circulation and the American Journal of Cardiology as well as a consultant for the National Institute of Health.

Dr. Katz currently serves on the board of directors for the Larry King Cardiac Foundation. Dr. Katz is a graduate of the New York University School of Medicine in 1972. He completed his cardiology fellowship in 1977 at the Georgetown University School of Medicine.